But the receptor agonist piece is crucial
The modified Tyrodes solution contained in millimolar concentrations (mM): 119.8 NaCI, 5.4 KCI, 1.8 CaCl 2 , 1.05 MgCl 2 , 0.42 NaH 2 PO 4 , 22.6 NaHCO 3 , 0.05 Na 2 EDTA, 0.28 ascorbic acid, and 5.05 glucose
1 in 8 adults in the US are currently taking a GLP-1 drug (2025), whether it be name brand or compounded
Protocol 3: metabolic health optimization Goal: Reduce liver fat, improve insulin sensitivity, address metabolic syndrome Tirzepatide approach: Standard escalation to 10 mg Produces moderate liver fat reduction Significant HbA1c improvements (if diabetic) Meaningful but not maximal metabolic improvements Retatrutide approach: Escalation to 8-12 mg 86% of patients achieved normal liver fat at 12 mg Superior metabolic marker improvements across all measures Glucagon component directly targets hepatic lipid metabolism If metabolic health is your primary goal rather than the number on the scale, the retatrutide dosage chart offers something tirzepatide fundamentally cannot: direct glucagon-mediated liver fat reduction
Tirzepatide is administered subcutaneously once weekly and works by activating GIP and GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite
A GLP-1 weight loss pill could be a game changer and one may be on the way
